Geneos Wealth Management’s Baxter International BAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.5K | Sell |
684
-20
| -3% | -$387 | ﹤0.01% | 1950 |
|
|
2025
Q4 | $13.5K | Buy |
704
+5
| +0.7% | +$100 | ﹤0.01% | 1871 |
|
|
2025
Q3 | $15.9K | Sell |
699
-78
| -10% | -$1.98K | ﹤0.01% | 1814 |
|
|
2025
Q2 | $23.5K | Sell |
777
-566
| -42% | -$17.2K | ﹤0.01% | 1955 |
|
|
2025
Q1 | $84.2K | Buy |
1,343
+513
| +62% | +$16.8K | ﹤0.01% | 1661 |
|
|
2024
Q4 | $24.2K | Sell |
830
-341
| -29% | -$11.5K | ﹤0.01% | 1630 |
|
|
2024
Q3 | $44.5K | Buy |
1,171
+897
| +327% | +$33K | ﹤0.01% | 1241 |
|
|
2024
Q2 | $9.16K | Buy |
274
+52
| +23% | +$1.92K | ﹤0.01% | 1569 |
|
|
2024
Q1 | $9.49K | Buy |
222
+5
| +2% | +$203 | ﹤0.01% | 1555 |
|
|
2023
Q4 | $8.39K | Buy |
217
+22
| +11% | +$778 | ﹤0.01% | 1590 |
|
|
2023
Q3 | $7.36K | Buy |
195
+10
| +5% | +$426 | ﹤0.01% | 1643 |
|
|
2023
Q2 | $8.43K | Hold |
185
| – | – | ﹤0.01% | 1619 |
|
|
2023
Q1 | $7.5K | Buy |
185
+164
| +781% | +$6.95K | ﹤0.01% | 1622 |
|
|
2022
Q4 | $1.07K | Buy |
21
+4
| +24% | +$215 | ﹤0.01% | 1956 |
|
|
2022
Q3 | $0 | Sell |
17
-2,663
| -99% | -$160K | ﹤0.01% | 2050 |
|
|
2022
Q2 | $175K | Sell |
2,680
-37
| -1% | -$2.69K | 0.01% | 790 |
|
|
2022
Q1 | $210K | Sell |
2,717
-941
| -26% | -$78.8K | 0.01% | 783 |
|
|
2021
Q4 | $314K | Buy |
3,658
+677
| +23% | +$54.5K | 0.01% | 720 |
|
|
2021
Q3 | $242K | Buy |
2,981
+79
| +3% | +$6.24K | 0.01% | 789 |
|
|
2021
Q2 | $237K | Sell |
2,902
-302
| -9% | -$25.3K | 0.01% | 779 |
|
|
2021
Q1 | $274K | Hold |
3,204
| – | – | 0.01% | 840 |
|
|
2020
Q4 | $248K | Sell |
3,204
-107
| -3% | -$8.48K | 0.01% | 756 |
|
|
2020
Q3 | $263K | Sell |
3,311
-1,084
| -25% | -$91.2K | 0.01% | 599 |
|
|
2020
Q2 | $370K | Buy |
4,395
+200
| +5% | +$17.4K | 0.02% | 482 |
|
|
2020
Q1 | $334K | Buy |
4,195
+920
| +28% | +$79.4K | 0.02% | 467 |
|
|
2019
Q4 | $275K | Hold |
3,275
| – | – | 0.01% | 584 |
|
|
2019
Q3 | $281K | Sell |
3,275
-74
| -2% | -$6.32K | 0.02% | 549 |
|
|
2019
Q2 | $274K | Hold |
3,349
| – | – | 0.02% | 571 |
|
|
2019
Q1 | $272K | Sell |
3,349
-2,637
| -44% | -$192K | 0.02% | 559 |
|
|
2018
Q4 | $390K | Buy |
5,986
+2,971
| +99% | +$200K | 0.03% | 426 |
|
|
2018
Q3 | $232K | Sell |
3,015
-33
| -1% | -$2.45K | 0.02% | 586 |
|
|
2018
Q2 | $225K | Hold |
3,048
| – | – | 0.02% | 539 |
|
|
2018
Q1 | $198K | Sell |
3,048
-150
| -5% | -$10.1K | 0.02% | 543 |
|
|
2017
Q4 | $206K | Sell |
3,198
-190
| -6% | -$12.2K | 0.02% | 527 |
|
|
2017
Q3 | $212K | Buy |
3,388
+1
| +0% | +$62 | 0.02% | 493 |
|
|
2017
Q2 | $205K | Buy |
3,387
+102
| +3% | +$5.79K | 0.02% | 490 |
|
|
2017
Q1 | $170K | Sell |
3,285
-95
| -3% | -$4.67K | 0.02% | 521 |
|
|
2016
Q4 | $149K | Sell |
3,380
-1,025
| -23% | -$47.4K | 0.02% | 522 |
|
|
2016
Q3 | $209K | Buy |
4,405
+157
| +4% | +$7.4K | 0.03% | 437 |
|
|
2016
Q2 | $193K | Sell |
4,248
-47
| -1% | -$2.06K | 0.03% | 452 |
|
|
2016
Q1 | $179K | Buy |
+4,295
| New | +$164K | 0.03% | 456 |
|
Other funds holding BAX
VCM
VPM
GA
Geneos Wealth Management's BAX Position: Q1 2026 in Review
Geneos Wealth Management reduced its Baxter International (BAX) stake by 2.8% in Q1 2026, selling an estimated $387 and leaving 684 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1950.
Geneos Wealth Management first reported a position in BAX in Q1 2016 and has held it in 41 quarters since. The position peaked at $390K in Q4 2018. 657 funds tracked by Wall St. Rank hold BAX as of Q1 2026.
- Geneos Wealth Management held 684 shares of Baxter International worth $11.5K as of Q1 2026.
- Geneos Wealth Management sold 20 Baxter International shares in Q1 2026, an estimated $387.
- Baxter International made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1950 holding.
- Geneos Wealth Management first reported a position in Baxter International in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Baxter International position peaked at $390K in Q4 2018.
- 657 funds tracked by Wall St. Rank held Baxter International as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.